Your browser doesnt support iframes.
MINNEAPOLIS (October 29, 2013) - Preventice®, Inc. announced today that Kevin Nickels has joined the company as chief operating officer. Nickels brings nearly 40 years experience in product and business development; general management; and an ability to raise and monetize invested capital —26 of which were spent at medical device companies—to his new role at Preventice. He will be responsible for leading the global market expansion of the BodyGuardian® Remote Monitoring System (BodyGuardian) and for continuing to evolve and enhance operations for the company’s remote monitoring solutions.
MINNEAPOLIS (Oct. 17, 2013) —Preventice®, Inc., announced today it has enhanced the ability of its BodyGuardian® Remote Monitoring System (BodyGuardian) to identify anomalous ECG rhythms and will now provide greater precision in identifying the type of arrhythmias that occurred when reporting events to care teams. The new capability supports the clinical scalability of BodyGuardian by increasing clinician efficiency as identified events are reviewed to confirm arrhythmia classifications.
European clinical trial interest remains strong; company poised for global distributionMINNEAPOLIS (October 9, 2013) —Preventice®, Inc., announced today that it has received CE Mark certification for its BodyGuardian® Remote Monitoring System from the European Commission.
Developed in collaboration with Mayo Clinic, the BodyGuardian uses sophisticated algorithms to support remote monitoring for individuals with cardiac arrhythmias. The BodyGuardian allows physicians to monitor key biometrics outside the clinical setting, while patients go about their daily lives. A small body sensor attached to the patient’s chest collects important data, including the patient’s ECG, heart rate, respiration rate and activity level. Patient data can then be transmitted to physicians via mobile phone technology. Remote patient monitoring can create a constant connection between patients and their care teams.
Healthcare industry leaders to provide clinical guidance for ongoing evolution of BodyGuardian Remote Monitoring System and remote monitoring capabilitiesMINNEAPOLIS (October 3, 2013) Preventice®, Inc., a leader in remote patient monitoring technology, announced today the appointment of a medical advisory board. The company tapped recognized leaders in clinical cardiology, patient monitoring technology, health sciences and nursing to guide the evolution of remote monitoring solutions, including the BodyGuardian® Remote Monitoring System, and to provide insight into the clinical needs of physicians, patients and life sciences companies.
“Preventice and the BodyGuardian are grounded in a mission to meet real-life clinical needs. Remote monitoring systems like BodyGuardian address the desire for technology that improves outcomes and saves money, without interrupting a patient’s normal daily activities or affecting their quality of life,” said Jon Otterstatter, co-founder, president and CEO of Preventice. “The medical advisory board will keep Preventice in touch with the changing needs of the professionals who prescribe and use the BodyGuardian, and the patients who benefit from this technology.”
MINNEAPOLIS (Sept. 3, 2013) —Preventice®, Inc., which produces the BodyGuardian® Remote Monitoring System (BodyGuardian RMS), announced today that it has received ISO 13485: 2003 certification.
MINNEAPOLIS (July 15, 2013) Michael Emerson, senior vice president of marketing for Preventice, will discuss the game-changing potential of remote monitoring technology and the BodyGuardian RMS during a presentation titled, “Connected Care Everywhere: Wearable Technologies,” at the Wearable Technologies Conference 2013. Emerson’s presentation will take place Tuesday, July 23 at 9:45 a.m., PT, at the Fort Mason Center in San Francisco, Calif.
Multiple clinical trials and pilot programs underscore growing interest in wireless patient monitoring technology
MINNEAPOLIS (February 27, 2013) Preventice, Inc. announced today that it will participate in the ACC.13, hosted by the American College of Cardiology on March 9-11, 2013 in San Francisco. ACC.13 is expected to attract more than 300 companies and organizations showcasing the latest advances in pharmaceuticals, imaging, devices, health IT, and services needed to treat cardiac patients. Preventice, a leading developer of mobile health solutions, will be on hand to showcase its breakthrough mobile health solutions for remote patient monitoring, patient education and patient engagement technologies.
MINNEAPOLIS (February 25, 2013) Preventice, Inc. announced today that it will take part in HIMSS 2013, March 3-7 in New Orleans. HIMSS is expected to attract thousands of health care executives, IT professionals and clinicians from around the world, including Preventice, which will showcase its breakthrough mobile health solutions for remote patient monitoring, patient education and ongoing patient engagement as part of the Qualcomm Life Pavillion.
MINNEAPOLIS (February 25, 2013) By all industry accounts, interest in remote patient monitoring is expected to remain strong in the coming years, as hospital readmission penalties in the United States take effect in 2013, and as mHealth technologies become more pervasive in the care delivery system, according to a report from Berg Insights. Berg analysts estimate that 2.8 million people are currently monitored for a variety of conditions outside the clinical setting. This number is expected to continue its upward trajectory, with cardiac rhythm management, sleep therapy and telehealth becoming the most significant categories for remote monitoring devices by 2017.